[go: up one dir, main page]

AU2871195A - Methods for the synthesis of diketopiperazines - Google Patents

Methods for the synthesis of diketopiperazines

Info

Publication number
AU2871195A
AU2871195A AU28711/95A AU2871195A AU2871195A AU 2871195 A AU2871195 A AU 2871195A AU 28711/95 A AU28711/95 A AU 28711/95A AU 2871195 A AU2871195 A AU 2871195A AU 2871195 A AU2871195 A AU 2871195A
Authority
AU
Australia
Prior art keywords
diketopiperazines
synthesis
methods
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU28711/95A
Inventor
David Campbell
Mark A. Gallop
Eric M. Gordon
Gary C Look
Dinesh Patel
Anna Katrin Szardenings
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Affymax Technologies NV
Original Assignee
Affymax Technologies NV
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from PCT/US1995/007878 external-priority patent/WO1995035278A1/en
Application filed by Affymax Technologies NV filed Critical Affymax Technologies NV
Publication of AU2871195A publication Critical patent/AU2871195A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D241/00—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
    • C07D241/02—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings
    • C07D241/06—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having one or two double bonds between ring members or between ring members and non-ring members
    • C07D241/08—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having one or two double bonds between ring members or between ring members and non-ring members with oxygen atoms directly attached to ring carbon atoms
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/54353—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals with ligand attached to the carrier via a chemical coupling agent
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Peptides Or Proteins (AREA)
AU28711/95A 1994-06-23 1995-06-23 Methods for the synthesis of diketopiperazines Abandoned AU2871195A (en)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
US26557894A 1994-06-23 1994-06-23
US265578 1994-06-23
US39331895A 1995-02-22 1995-02-22
US393318 1995-02-22
PCT/US1995/007878 WO1995035278A1 (en) 1994-06-22 1995-06-22 Methods for synthesizing diverse collections of pyrrolidine compounds
WOUS9507878 1995-06-22
PCT/US1995/007964 WO1996000391A1 (en) 1994-06-23 1995-06-23 Methods for the synthesis of diketopiperazines

Publications (1)

Publication Number Publication Date
AU2871195A true AU2871195A (en) 1996-01-19

Family

ID=27377866

Family Applications (1)

Application Number Title Priority Date Filing Date
AU28711/95A Abandoned AU2871195A (en) 1994-06-23 1995-06-23 Methods for the synthesis of diketopiperazines

Country Status (2)

Country Link
AU (1) AU2871195A (en)
WO (1) WO1996000391A1 (en)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5990112A (en) * 1996-06-18 1999-11-23 Affymax Technologies N.V. Inhibitors of metalloproteases pharmaceutical compositions comprising same and methods of their use
US5811241A (en) * 1995-09-13 1998-09-22 Cortech, Inc. Method for preparing and identifying N-substitued 1,4-piperazines and N-substituted 1,4-piperazinediones
US5846839A (en) * 1995-12-22 1998-12-08 Glaxo Group Limited Methods for hard-tagging an encoded synthetic library
DE19610103A1 (en) 1996-03-15 1997-09-18 Basf Ag Cycloalkyl derivatives and their synthesis on solid phase
DE19621177A1 (en) 1996-05-24 1997-11-27 Basf Ag Carbohydrate derivatives and their synthesis on solid phase
US5932579A (en) 1996-06-18 1999-08-03 Affymax Technologies N.V. Collagenase-1 and stromelysin-1 inhibitors, pharmaceutical compositions comprising same and methods of their use
DE19626762A1 (en) 1996-07-03 1998-01-08 Basf Ag Enzymatically cleavable linker for solid phase synthesis
KR19990071182A (en) * 1998-02-27 1999-09-15 성재갑 Method for preparing diketopiperazine derivatives using solid phase reaction
US6713309B1 (en) 1999-07-30 2004-03-30 Large Scale Proteomics Corporation Microarrays and their manufacture
US7179638B2 (en) 1999-07-30 2007-02-20 Large Scale Biology Corporation Microarrays and their manufacture by slicing
CN100553636C (en) 2000-08-04 2009-10-28 Dmi生物科学公司 Methods of use of diketopiperazines and compositions containing them
WO2002012201A1 (en) 2000-08-04 2002-02-14 Dmi Biosciences, Inc. Method of synthesizing diketopiperazines
AU2001297611A1 (en) 2000-12-29 2002-08-19 Celltech R And D, Inc. Pharmaceutical uses and synthesis of diketopiperazines
DK1571970T3 (en) 2002-10-02 2011-11-28 Dmi Biosciences Inc Diagnosis and monitoring of diseases
KR20120091266A (en) 2003-05-15 2012-08-17 디엠아이 바이오사이언시스, 인크 Treatment of t-cell mediated diseases
JP5856843B2 (en) 2008-05-27 2016-02-10 アンピオ ファーマシューティカルズ，インコーポレイテッド Pharmaceutical composition using diketopiperazine
ES2727711T3 (en) * 2009-07-30 2019-10-18 Spiral Therapeutics Inc Apaf-1 inhibitor compounds
WO2012033792A2 (en) 2010-09-07 2012-03-15 Dmi Acquisition Corp. Treatment of diseases
BR112014007657A2 (en) 2011-10-10 2017-04-11 Ampio Pharmaceuticals Inc Implantable medical devices with improved immune tolerance and methods for production and implantation
MX362164B (en) 2011-10-10 2019-01-07 Ampio Pharmaceuticals Inc Treatment of degenerative joint disease.
SG11201400283RA (en) 2011-10-28 2014-03-28 Ampio Pharmaceuticals Inc Treatment of rhinitis
SG10201707619RA (en) 2013-03-15 2017-10-30 Ampio Pharmaceuticals Inc Compositions for the mobilization, homing, expansion and differentiation of stem cells and methods of using the same
WO2015194035A1 (en) * 2014-06-20 2015-12-23 サントリーホールディングス株式会社 Cyclic dipeptide-containing composition
EP3183240A4 (en) 2014-08-18 2018-06-27 Ampio Pharmaceuticals, Inc. Treatment of joint conditions
HK1246669A1 (en) 2015-06-22 2018-09-14 Ampio Pharmaceuticals, Inc. Use of low molecular weight fractions of human serum albumin in treating diseases
US10561736B1 (en) 2019-01-09 2020-02-18 Spiral Therapeutics, Inc. Apoptosis inhibitor formulations for prevention of hearing loss
WO2021195265A1 (en) 2020-03-24 2021-09-30 Ampio Pharmaceuticals, Inc. Methods for treating diseases associated with respiratory viruses

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5650489A (en) * 1990-07-02 1997-07-22 The Arizona Board Of Regents Random bio-oligomer library, a method of synthesis thereof, and a method of use thereof
US5324483B1 (en) * 1992-10-08 1996-09-24 Warner Lambert Co Apparatus for multiple simultaneous synthesis

Also Published As

Publication number Publication date
WO1996000391A1 (en) 1996-01-04

Similar Documents

Publication Publication Date Title
AU2871195A (en) Methods for the synthesis of diketopiperazines
AU2657095A (en) Synthesis of oligonucleotides
AU4237896A (en) Method and intermediates for the synthesis of korupensamines
AU3224497A (en) Processes for the synthesis of sialyl lewisx compounds
AU2734895A (en) Process for the preparation of 3-aryluracils
AU3284395A (en) Synthesis of 1,1,1,3,3,-pentafluoropropane
AU3868095A (en) Apolipoprotein-b synthesis inhibitors
AU5871196A (en) Methods and compounds for the synthesis of oligonucleotides and the oligonucleotides thereby produced
AU5372598A (en) Tfpx synthesis
AU2377095A (en) Apparatus for the manufacture of innerspring constructions
AU1230595A (en) Process for the preparation of polyalkyl-1-oxa- diazaspirodecane compounds
AU5381696A (en) Synthesis of bis-indolylmaleimides
AU8758298A (en) Process for the preparation of 2'-fluoro-5-methyl-beta -l-arabinofuranosyluridine
AU2217797A (en) Synthesis of indolylmaleimides
AU4157097A (en) Synthesis of bisindolylmalimides
AU1602995A (en) Methods for the solid phase synthesis of glycoconjugates
IL129868A0 (en) Process for the synthesis of benzothiopenes
AU3731595A (en) Improved process for the preparation of 5-aminotetrazole
AU3783097A (en) Process for the preparation of hexanitrohexaazaisowurtzitanes
AU4712696A (en) The use of heterocyclic compounds
AU3948395A (en) Synthesis of 6-azaandrostenones
AU1838795A (en) Methods for the synthesis of chemical compounds
AU2320895A (en) Polyalkylpiperidine compounds
AU7752698A (en) Method for the synthesis of anti-microbial hydroxybenzoats
AU1870295A (en) Novel derivatives of tetramethylcyclopropane